Rare diseases
Investigational molecules
Locations
A study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy
BelgiumA Study of Cannabidiol for Sleep Quality After Evening Exercise in Healthy People
BelgiumA study testing the safety and effectiveness of infigratinib compared to placebo in infants and young children with achondroplasia
NorwayStudy of ECI830, ribociclib, and fulvestrant in patients with advanced hormone receptor positive, HER2-negative breast cancer and advanced solid tumors
CzechiaA study testing etentamig alone or with drug combinations in adult patients with multiple myeloma to assess safety and changes in disease activity
NorwayA study comparing furazidin and clindamycin for women with bacterial vaginosis
CzechiaTesting the Safety of Dendritic Cell and CAR-T Cell Combination Therapy in Patients with Newly Diagnosed Diffuse Intrinsic Pontine Glioma
SpainA study testing the safety and effects of ADS-019 in adults aged 18 to 65 years with type 1 myotonic dystrophy
BelgiumStudy of glepaglutide compared to placebo for patients with short bowel syndrome with intestinal failure
AustriaA study testing ACT-1004-1239 compared to placebo for adults with progressive multiple sclerosis to measure nerve repair using MRI scans
The NetherlandsA study testing GSK3862995B compared to placebo for safety and effectiveness in adults aged 18 to 85 years with bronchiectasis
DenmarkA Study of CND261 for Patients with Active ANCA-Positive Vasculitis That Has Not Responded to Previous Treatments
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
